Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

China’s First Home Grown Novel HIV Drug Shoots For Prime Time

Executive Summary

With a fast-growing HIV population and reliance on older-generation treatments, China could become the next frontier for new antiretroviral drugs. Government support might see the country’s first novel locally developed, long-lasting injectable product take on the big names in the field.

Advertisement

Related Content

Venture Funding Deals: Takeda Ups Its Bet On Immuno-Oncology Play Maverick
2016 Review: Rapid Change Defines China Regulatory Environment
GSK/Desano Tie-Up To Bring Large Dolutegravir Price Cuts

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register